Ruvazone

Usually used to synthesize N′-[(E)-5-bromo-2-hydroxy-3-methoxybenzylidene]-4-methoxybenzohydrazide monohydrate,2,5-bis(4-methoxyphenyl)-1,3,4-oxadiazole,hydrazone ligands, which readily forms ruthenium(II) hydrazone complexes via reaction with

Usually used to synthesize N′-[(E)-5-bromo-2-hydroxy-3-methoxybenzylidene]-4-methoxybenzohydrazide monohydrate,2,5-bis(4-methoxyphenyl)-1,3,4-oxadiazole,hydrazone ligands, which readily forms ruthenium(II) hydrazone complexes via reaction with

Usually used to synthesize N′-[(E)-5-bromo-2-hydroxy-3-methoxybenzylidene]-4-methoxybenzohydrazide monohydrate,2,5-bis(4-methoxyphenyl)-1,3,4-oxadiazole,hydrazone ligands, which readily forms ruthenium(II) hydrazone complexes via reaction with

Usually used to synthesize N′-[(E)-5-bromo-2-hydroxy-3-methoxybenzylidene]-4-methoxybenzohydrazide monohydrate,2,5-bis(4-methoxyphenyl)-1,3,4-oxadiazole,hydrazone ligands, which readily forms ruthenium(II) hydrazone complexes via reaction with

Usually used to synthesize N′-[(E)-5-bromo-2-hydroxy-3-methoxybenzylidene]-4-methoxybenzohydrazide monohydrate,2,5-bis(4-methoxyphenyl)-1,3,4-oxadiazole,hydrazone ligands, which readily forms ruthenium(II) hydrazone complexes via reaction with

Usually used to synthesize N′-[(E)-5-bromo-2-hydroxy-3-methoxybenzylidene]-4-methoxybenzohydrazide monohydrate,2,5-bis(4-methoxyphenyl)-1,3,4-oxadiazole,hydrazone ligands, which readily forms ruthenium(II) hydrazone complexes via reaction with

Growth/differentiation factor 2 (UniPort: Q9UK05 also known as GDF-2, Bone morphogenetic protein 9, BMP-9) is encoded by the GDF2 (also known as BMP9) gene (Gene ID: 2658) in human. BMP-9 is a member of the TGF-beta family that forms a signaling

Bone morphogenetic protein 2 (UniProt: P12643 also known as BMP-2, BMP-2A, Bone morphogenetic protein 2A) is encoded by the BMP2 (also known as BMP2A) gene (Gene ID 650) in human. BMP2 is a member of the transforming growth factor-beta (TGF-beta)

Anti-RXRG retinoid X receptor gamma, 25ul UN 1687 6.1 PG2

A gold-thiol complex with anti-inflammatory and immunosuppressive actions potently inhibits thioredoxin reductase (IC₅₀ = 0.2 &muM) blocks LPS-mediated expression of inflammatory mediators at 10-20 &muM and blocks NF-&kappaB

A gold-thiol complex with anti-inflammatory and immunosuppressive actions potently inhibits thioredoxin reductase (IC₅₀ = 0.2 &muM) blocks LPS-mediated expression of inflammatory mediators at 10-20 &muM and blocks NF-&kappaB

InformationGSK046 GSK046 (iBET-BD2) is a selective and orally active inhibitor of BET (bromodomain and extraterminal domain) with IC50 of 264 nM, 98 nM, 49 nM and 214 nM for BRD2 BD2 , BRD3 BD2 , BRD4 BD2 and BRDT BD2 , respectively. GSK046 exhibits